[1]
Gupta, R.D. and Noman, M.U. 2024. Sparsentan: Sparsentan- A novel, non- immunosuppressive, dual action angiotensin II and endothelin A receptor antagonist -A new hope for glomerular disease. Journal of Shaheed Suhrawardy Medical College. 14, 2 (May 2024), 58–62. DOI:https://doi.org/10.3329/jssmc.v14i2.73180.